Abstract P193 Table 1

Least squares mean (LSM) treatment difference on Day 1 and Week 26

	Total number of patients (n)	LSM treatment difference (SE) in mL

		Glycopyrronium–placebo	Tiotropium–placebo	Glycopyrronium–tiotropium

Day 1
FEV₁ AUC_0–4h	1165	190 (9)^*	140 (9)^*	50 (8)^*
FEV₁ AUC_0–12h	164	180 (25)^*	130 (25)^*	50 (20)^†
Week 26
FEV₁ AUC_0–12h	152	210 (41)^*	210 (41)^*	–10 (33)^NS
FEV₁ AUC_12–24h	152	200 (43)^*	210 (42)^*	–10 (33)^NS
FEV₁ AUC_0–24h	152	200 (41)^*	210 (40)^*	–10 (32)^NS